

Skylark Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 10.50 Cr
- Revenue Growth -40.32%
- Profit Growth -11.33%
- Ebitda -218.45%
- Net Worth -12.91%
- Total Assets -6.84%
About Skylark Pharmaceuticals
Skylark Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 July 2005 and has a history of 19 years and eight months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹10.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukesh Chadderwala, Kamleshkumar Patel, and Prakashbhai Chadderwala serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ2005PTC046440
- Company No.
046440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Skylark Pharmaceuticals Private Limited offer?
Skylark Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Digestive Drugs, Antiemetic Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules.
Who are the key members and board of directors at Skylark Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prakashbhai Chadderwala ![]() | Director | 11-Apr-2013 | Current |
Mukesh Chadderwala ![]() | Director | 18-Jul-2005 | Current |
Kamleshkumar Patel ![]() | Director | 18-Jul-2005 | Current |
Financial Performance of Skylark Pharmaceuticals.
Skylark Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 40.32% decrease. The company also saw a substantial fall in profitability, with a 11.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.91%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Skylark Pharmaceuticals?
Unlock access to Skylark Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Related Corporates (Common Directorship)
- Neelkanth Lease Finance Limited
Mukesh Chadderwala and Prakashbhai Chadderwala are mutual person
- Megastar Chemicals Private Limited
Mukesh Chadderwala is a mutual person
- Mnc Realty Private Limited
Mukesh Chadderwala is a mutual person
Charges (Loans)
₹0
₹10.50 Cr
Charges Breakdown by Lending Institutions
- Prime Co-Operative Bank Limited : 8.00 Cr
- Others : 2.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Oct 2020 | Others | ₹1.00 Cr | Satisfied |
04 Jun 2016 | Others | ₹1.50 Cr | Satisfied |
19 Feb 2014 | Prime Co-Operative Bank Limited | ₹5.50 Cr | Satisfied |
01 Jan 2014 | Prime Co-Operative Bank Limited | ₹2.50 Cr | Satisfied |
How Many Employees Work at Skylark Pharmaceuticals?
Skylark Pharmaceuticals has a workforce of 6 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Skylark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skylark Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Skylark Pharmaceuticals
Recent activity within the organization
- Charges
A charge registered on 29 Oct 2020 via Charge ID 100387720 with Others was fully satisfied on 25 Nov 2024.
- Charges
A charge registered on 04 Jun 2016 via Charge ID 100034244 with Others was fully satisfied on 25 Nov 2024.
- Charges
A charge registered on 19 Feb 2014 via Charge ID 10480639 with Prime Co-Operative Bank Limited was fully satisfied on 25 Nov 2024.
- Charges
A charge registered on 01 Jan 2014 via Charge ID 10473923 with Prime Co-Operative Bank Limited was fully satisfied on 25 Nov 2024.
- Annual General Meeting
Skylark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Skylark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Frequently asked questions
What is the Incorporation or founding date of Skylark Pharmaceuticals Private Limited?
Skylark Pharmaceuticals Private Limited was incorporated on 18 Jul 2005.
What is authorized share capital and paid-up capital of Skylark Pharmaceuticals Private Limited?
The authorized share capital of Skylark Pharmaceuticals Private Limited is ₹ 7.00 Cr and paid-up capital is ₹ 1.00 Cr.
Who are the current board members & directors of Skylark Pharmaceuticals Private Limited?
Currently 3 directors are associated with Skylark Pharmaceuticals Private Limited.
- Mukesh Narbheram Chadderwala
- Kamleshkumar Gaurishankar Patel
- Prakashbhai Narbhaeram Chadderwala
What is the registered address of Skylark Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Skylark Pharmaceuticals Private Limited is Plot No. 7910 Gidc India, Ankleshwar, Gujarat, 393002.
What is the corporate identification number (CIN) and company number of Skylark Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Skylark Pharmaceuticals Private Limited is U24230GJ2005PTC046440 and the company number is 046440 as per Ministry of Corporate Affairs (MCA).
What is the official website of Skylark Pharmaceuticals Private Limited?
The Official website of Skylark Pharmaceuticals Private Limited is https://www.skylarkpharmaceuticals.com
What has been the recent revenue trend for Skylark Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Skylark Pharmaceuticals Private Limited has fallen by -40.32%.
How many employees does Skylark Pharmaceuticals Private Limited currently have?
As Per 2024 financial reports, 6 employees are currently employed by Skylark Pharmaceuticals Private Limited.
What change has been observed in the net worth of Skylark Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Skylark Pharmaceuticals Private Limited has experienced an downturn of -12.91%.
When was the last Balance Sheet of Skylark Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Skylark Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
KC
Kapilaben ChadderwalaDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India